Published • loading... • Updated
Novo Partners with Anthropic to Speed up Drug Development with Claude
Novo will test Claude Science in research workflows and automate trial reporting as drugmakers increasingly turn to AI, the companies said.
- On Sept 16, Novo Nordisk partnered with Anthropic to utilize Claude models for accelerating medicine discovery and development. The Danish drugmaker will initially test Anthropic models and Claude Science in research and development workflows.
- Drugmakers are increasingly adopting artificial intelligence to accelerate research pipelines. The Wegovy maker intends to leverage Anthropic frontier models to strengthen AI-driven software development.
- Novo already utilizes Claude to automate trial report generation, successfully trimming timelines for patient documentation from months to minutes.
- "AI tools can also offer completely new scientific opportunities," Novo CEO Mike Doustdar said. Anthropic CEO Dario Amodei noted frontier models can shorten research timelines and improve outcomes.
- Industry leaders remain split over how rapidly companies should develop next-generation technology, even as the agreement underscores growing integration of advanced models across the pharmaceutical sector.
Insights by Ground AI
Podcasts & Opinions
48 Articles
48 Articles
Novo Nordisk deepens its AI push with Anthropic partnership
Novo Nordisk is partnering with Anthropic to use artificial intelligence to accelerate the discovery and development of new medicines, Inc. reports. The Danish pharmaceutical company, known for Wegovy and Ozempic, will explore how Anthropic’s Claude Science tools can help researchers analyze complex data, investigate human biology and better understand how drugs work. Novo also plans […]
DANISH pharmaceutical company Novo, the maker of Ozempic, has partnered with AI company Anthropic to accelerate the development of new drugs using the Claude artificial intelligence model.
·Zagreb, Croatia
Read Full Article
Coverage Details
Total News Sources48
Leaning Left5Leaning Right11Center12Last UpdatedBias Distribution43% Center
Bias Distribution
- 43% of the sources are Center
43% Center
L 18%
C 43%
R 39%
Factuality
To view factuality data please Upgrade to Premium
